Raymond James & Associates »

Ocuphire Pharma shares owned by Raymond James & Associates

Quarter-by-quarter ownership of Ocuphire Pharma (IRD) shares owned by Raymond James & Associates from 13F filings

Historical chart of Raymond James & Associates investment in Ocuphire Pharma

Tip: Access up to 7 years of quarterly data

All positions including Ocuphire Pharma held by Raymond James & Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ocuphire Pharma by Raymond James & Associates

Quarter filed Position value Share count Share price at filing
2024-09-30 $15k 12k 1.31

More positions owned by Raymond James & Associates

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Core Us Aggbd Et (AGG)
Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Ishares Tr Core Msci Eafe (IEFA)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core S&p Mcp Etf (IJH)
Alphabet Cap Stk Cl A (GOOGL)
Meta Platforms Cl A (META)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Home Depot (HD)
UnitedHealth (UNH)

View all positions for Raymond James & Associates

Top funds holding Ocuphire Pharma

Geode Capital Management
Richmond Brothers
BlackRock
Citadel Advisors
Knoll Capital Management
Renaissance Technologies
Susquehanna International
Kestra Private Wealth Services
Empowered Funds
William Blair $ Company
Diametric Capital
Trust Co Of Toledo Na
Brian McDonald
Northern Trust
Virtu Financial

View all funds holding Ocuphire Pharma